相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Restoration of Aberrant Shape of Caudate Subregions Associated with Cognitive Function Improvement in Mild Traumatic Brain Injury
Hui Xu et al.
JOURNAL OF NEUROTRAUMA (2022)
Extrastriatal Dopamine D2/3 Receptor Availability in Alcohol Use Disorder and Individuals at High Risk
Gianna Spitta et al.
NEUROPSYCHOBIOLOGY (2022)
Altered Structural and Functional Connectivity of Salience Network in Patients with Classic Trigeminal Neuralgia
Hui Xu et al.
JOURNAL OF PAIN (2022)
Aberrant hippocampal shape development in young adults with heavy cannabis use: Evidence from a longitudinal study
Hui Xu et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2022)
Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders
Muhammad Yousaf et al.
MOLECULES (2022)
Fatty acid amide hydrolase is lower in young cannabis users
Maya R. Jacobson et al.
ADDICTION BIOLOGY (2021)
Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder
Deepak Cyril D'Souza et al.
MOLECULAR PSYCHIATRY (2021)
Cannabis use and cannabis use disorder
Jason P. Connor et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Brain imaging of cannabinoid type I (CB1) receptors in women with cannabis use disorder and male and female healthy controls
Tory R. Spindle et al.
ADDICTION BIOLOGY (2021)
Dynamic coupling of whole-brain neuronal and neurotransmitter systems
Morten L. Kringelbach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Deconstructing the neurobiology of cannabis use disorder
Jacqueline-Marie N. Ferland et al.
NATURE NEUROSCIENCE (2020)
PET technology for drug development in psychiatry
Ryosuke Arakawa et al.
NEUROPSYCHOPHARMACOLOGY REPORTS (2020)
New trends in cannabis potency in USA and Europe during the last decade (2008-2017)
Suman Chandra et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
Functional and Structural Neuroimaging Studies of Delayed Reward Discounting in Addiction: A Systematic Review
Max M. Owens et al.
PSYCHOLOGICAL BULLETIN (2019)
In Vivo Imaging of Translocator Protein in Long-term Cannabis Users
Tania Da Silva et al.
JAMA PSYCHIATRY (2019)
Sex difference in brain CB1 receptor availability in man
Heikki Laurikainen et al.
NEUROIMAGE (2019)
Methylphenidate's effects on thalamic metabolism and functional connectivity in cannabis abusers and healthy controls
Sukru Baris Demiral et al.
NEUROPSYCHOPHARMACOLOGY (2019)
The neuropsychopharmacology of cannabis: A review of human imaging studies
Michael A. P. Bloomfield et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Changes in the prevalence and correlates of cocaine use and cocaine use disorder in the United States, 2001-2002 and 2012-2013
Bradley T. Kerridge et al.
ADDICTIVE BEHAVIORS (2019)
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
Arnau Busquets-Garcia et al.
NEUROPSYCHOPHARMACOLOGY (2018)
US Epidemiology of Cannabis Use and Associated Problems
Deborah S. Hasin
NEUROPSYCHOPHARMACOLOGY (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cannabis Addiction and the Brain: a Review
Amna Zehra et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2018)
Deficits in striatal dopamine release in cannabis dependence
E. van de Giessen et al.
MOLECULAR PSYCHIATRY (2017)
The endocannabinoid system as a target for addiction treatment: Trials and tribulations
Matthew E. Sloan et al.
NEUROPHARMACOLOGY (2017)
Changes in US Lifetime Heroin Use and Heroin Use Disorder Prevalence From the 2001-2002 to 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions
Silvia S. Martins et al.
JAMA PSYCHIATRY (2017)
Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine A Systematic Review and Meta-analysis
Abhishekh H. Ashok et al.
JAMA PSYCHIATRY (2017)
Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III
Deborah S. Hasin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C] CURB
Isabelle Boileau et al.
BIOLOGICAL PSYCHIATRY (2016)
Phytocannabinoids: a unified critical inventory
Lumir Ondrej Hanus et al.
NATURAL PRODUCT REPORTS (2016)
The effects of Δ9-tetrahydrocannabinol on the dopamine system
Michael A. P. Bloomfield et al.
NATURE (2016)
Cannabis Abusers Show Hypofrontality and Blunted Brain Responses to a Stimulant Challenge in Females but not in Males
Corinde E. Wiers et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Balanced modulation of striatal activation from D2/D3 receptors in caudate and ventral striatum: Disruption in cannabis abusers
Dardo Tomasi et al.
HUMAN BRAIN MAPPING (2015)
Imaging the cannabinoid CB1 receptor in humans with [C-11]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences
Marc D. Normandin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Pitfalls and Limitations of PET/CT in Brain Imaging
Eric Salmon et al.
SEMINARS IN NUCLEAR MEDICINE (2015)
Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013
Deborah S. Hasin et al.
JAMA PSYCHIATRY (2015)
[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users
Jenny Ceccarini et al.
ADDICTION BIOLOGY (2015)
Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
Michael A. P. Bloomfield et al.
BIOLOGICAL PSYCHIATRY (2014)
Early phytocannabinoid chemistry to endocannabinoids and beyond
Raphael Mechoulam et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity
Nora D. Volkow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study
Michael A. P. Bloomfield et al.
PSYCHOPHARMACOLOGY (2014)
The Endocannabinoid System and the Brain
Raphael Mechoulam et al.
ANNUAL REVIEW OF PSYCHOLOGY, VOL 64 (2013)
Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2013)
Power failure: why small sample size undermines the reliability of neuroscience
Katherine S. Button et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO
Romina Mizrahi et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Design Considerations for using PET as a Response Measure in Single Site and Multicenter Clinical Trials
Robert K. Doot et al.
ACADEMIC RADIOLOGY (2012)
Dopamine Release in Chronic Cannabis Users: A [11C]Raclopride Positron Emission Tomography Study
Nina B. L. Urban et al.
BIOLOGICAL PSYCHIATRY (2012)
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers
J. Hirvonen et al.
MOLECULAR PSYCHIATRY (2012)
Chronic Δ9-Tetrahydrocannabinol Exposure Induces a Sensitization of Dopamine D2/3 Receptors in the Mesoaccumbens and Nigrostriatal Systems
Nathalie Ginovart et al.
NEUROPSYCHOPHARMACOLOGY (2012)
A MOLECULAR IMAGING PRIMER: MODALITIES, IMAGING AGENTS, AND APPLICATIONS
Michelle L. James et al.
PHYSIOLOGICAL REVIEWS (2012)
GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
Zheng-Xiong Xi et al.
NATURE NEUROSCIENCE (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Actions of delta-9-tetrahydrocannabinol in cannabis: Relation to use, abuse, dependence
Ziva D. Cooper et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2009)
Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography
Serge Sevy et al.
PSYCHOPHARMACOLOGY (2008)
Behavioral functions of the mesolimbic dopaminergic system: An affective neuroethological perspective
Antonio Alcaro et al.
BRAIN RESEARCH REVIEWS (2007)
Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators
Chui-Se Tham et al.
FEBS LETTERS (2007)
Two brain sites for cannabinoid reward
A Zangen et al.
JOURNAL OF NEUROSCIENCE (2006)
Neural substrates of faulty decision-making in abstinent marijuana users
KI Bolla et al.
NEUROIMAGE (2005)
Imaging addiction with PET: is insight in sight?
WK Schiffer et al.
DRUG DISCOVERY TODAY (2005)
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence
B Le Foll et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Abnormal brain activity in prefrontal brain regions in abstinent marijuana users
DA Eldreth et al.
NEUROIMAGE (2004)
PET/CT:: a new imaging technology in nuclear medicine
H Schöder et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens
BL Hungund et al.
JOURNAL OF NEUROCHEMISTRY (2003)
SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats
C Cohen et al.
BEHAVIOURAL PHARMACOLOGY (2002)
Positron emission tomography provides molecular imaging of biological processes
ME Phelps
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
